Akebia Therapeutics
AKBA
#9606
Rank
A$0.16 B
Marketcap
A$0.58
Share price
-8.71%
Change (1 day)
-76.38%
Change (1 year)

Akebia Therapeutics (AKBA) - Total debt

Total debt on the balance sheet as of June 2026 : A$83.04 Million

According to Akebia Therapeutics's latest financial reports the company's total debt is A$83.04 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Akebia Therapeutics - Total debt on balance sheet (from 2013 to 2026)

Total debt by year

Year Total debt Change
2025-12-31A$77.33 M0.97%
2024-12-31A$76.59 M8.44%
2023-12-31A$70.63 M-51.83%
2022-12-31A$0.14 B-21.86%
2021-12-31A$0.18 B14.26%
2020-12-31A$0.16 B6.15%
2019-12-31A$0.15 B626.62%
2018-12-31A$21.29 M
2013-12-31A$0.01 M
2012-12-31N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
A$67.45 B 81,129.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$72.98 B 87,785.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
A$86.57 B 104,147.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
A$0.11 B 42.91%๐Ÿ‡บ๐Ÿ‡ธ USA